Digestive and Liver Disease

Article	Citations
Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial	89
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies	73
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis	71
Systemic inflammation as fuel for acute liver injury in COVID-19	63
COVID 19 and liver: An A–Z literature review	62
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis	61
Foreign body and caustic ingestions in children: A clinical practice guideline	57
Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review	55
Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway	50
Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map	49
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD	48
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population	45
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function	43
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging	42
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey	42
COVID-19 and intestinal inflammation: Role of fecal calprotectin	41
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease	41
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment	39
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis	39
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis	37
Gastritis: The clinico-pathological spectrum	36
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)	36
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis	34
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data	34
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection	33

Italian guidelines for the management of irritable bowel syndrome	31
Update on gastroenteropancreatic neuroendocrine tumors	30
Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis	30
Seronegative autoimmune atrophic gastritis is more common in elderly patients	29
COVID-19 in IBD: The experience of a single tertiary IBD center	29
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19	28
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey	28
PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance	27
Covid-19 and alcohol associated liver disease	27
Endoscopic ultrasound-guided vs ERCP-guided biliary drainage for malignant biliary obstruction: A up-to-date meta-analysis and systematic review	26
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology	25
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population	24
Splanchnic vein thrombosis in COVID-19: A review of literature	24
Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages	24
Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children	24
Guidelines of the Italian societies of gastroenterology on the diagnosis and management of coeliac disease and dermatitis herpetiformis	23
The impact of reader fatigue on the accuracy of capsule endoscopy interpretation	23
Systematic Review: esophageal motility patterns in patients with eosinophilic esophagitis	23
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients	23
Circ-SMARCA5 suppresses colorectal cancer progression via downregulating miR-39-3p and upregulating ARID4B	23
Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma	23
Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus	22
The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up	22
Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study	21
Ultrasound-guided stellate ganglion block alleviates stress responses and promotes recovery of gastrointestinal function in patients	21
Vaccinations and inflammatory bowel disease – a systematic review	21
Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis	21
The Baveno VII concept of cirrhosis recompensation	20
Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2	20
Time course and risk factors of evolution from potential to overt autoimmune gastritis	20
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation	20
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group	20
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study	20
MAFLD vs NAFLD: Where are we?	20
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry	20
Colectomy rates in ulcerative colitis: A systematic review and meta-analysis	20
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population	20
Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region	19
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs	19
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease	19
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis	19
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis	19
Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension	19
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis	19
Treatment of primary sclerosing cholangitis	19
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic	19
Clinical management and patient outcomes of acute lower gastrointestinal bleeding. A multicenter, prospective, cohort study	18
Female reproductive health and inflammatory bowel disease: A practice-based review	18
The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients	18
Painless chronic pancreatitis	18

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian S	17
LncRNA miR503HG inhibits epithelial-mesenchymal transition and angiogenesis in hepatocellular carcinoma by enhancing PDCD4 via regulation of miR-15b	17
Esophageal reflux hypersensitivity: Non-GERD or still GERD?	17
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial	17
Hepatitis B reactivation and immune check point inhibitors	17
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study	17
A deep learning method to assist with chronic atrophic gastritis diagnosis using white light images	17
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group	17
Long term results of liver transplantation for alpha-1 antitrypsin deficiency	17
Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review	17
Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort.	17
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed	16
Intelligent detection endoscopic assistant: An artificial intelligence-based system for monitoring blind spots during esophagogastroduodenoscopy in real-time	16
FAPI PET/CT research progress in digestive system tumours	16
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus	16
Sustainability in gastroenterology and digestive endoscopy: Position Paper from the Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO)	16
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFR	16
NAFLD, MAFLD and DAFLD	16
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study	16
Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem?	16
Onset of ulcerative colitis during SARS-CoV-2 infection	16
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group	16
Clinical application of carbon nanoparticles in lymphatic mapping during colorectal cancer surgeries: A systematic review and meta-analysis	16
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort	16
HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro	15
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel	15
Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis	15
Current treatment options of refractory ascites in liver cirrhosis – A systematic review and meta-analysis	15
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study	15
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis	15
Clinical impact of videocapsule and double balloon enteroscopy on small bowel bleeding: Results from a large monocentric cohort in the last 19 years	15
Genetic and non-genetic risk factors for early-onset pancreatic cancer	15
Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis	15
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis	15
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis	15
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group	14
The global, regional, and national burden of inflammatory bowel diseases, 1990–2019: A systematic analysis for the global burden of disease study 2019	14
Vaccinations in patients with inflammatory bowel disease	14
WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability	14
Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry	14
Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators	14
Systematic review and meta-analysis: Artificial intelligence for the diagnosis of gastric precancerous lesions and Helicobacter pylori infection	14
MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis	14
Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease	14
Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function	14
Gastric microbiota composition in patients with corpus atrophic gastritis	14
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure	14
The application of artificial intelligence in hepatology: A systematic review	14
B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment	14
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial	14
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19	13
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study	13
Exposed endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors: A systematic review and pooled analysis	13
Higher rate of en bloc resection with underwater than conventional endoscopic mucosal resection: A meta-analysis	13
Early microscopic findings in preclinical inflammatory bowel disease	13
Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study	13
Collagenous gastritis: Epidemiology and clinical associations	13
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank	13
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic	13
Effectiveness of a screening program for HBV, HCV, and HIV infections in African migrants to Sicily	13
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines	13
Italian association for the study of the liver position statement on SARS-CoV2 vaccination	13
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy	13
Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies	13
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis	13
MiR-21 regulates epithelial–mesenchymal transition in intestinal fibrosis of Crohn's disease by targeting PTEN/mTOR	12
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF)	12
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis	12
Low frequency of COVID-19 in inflammatory bowel diseases	12
Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP	12
Spontaneous portosystemic shunts in cirrhosis: Detection, implications, and clinical associations	12
Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry	12
Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience	12
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease	12
Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts	12
Post COVID-19 cholangiopathy – A deep dive	12
CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer	12
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology	12
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers	12
High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina	12

Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study	12
Relationship between duodenal microbiota composition, clinical features at diagnosis, and persistent symptoms in adult Coeliac disease	12
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices	12
Uncontrolled diabetes mellitus increases risk of infection in patients with advanced cirrhosis	12
Cytomegalovirus gastritis: Clinicopathological profile	11
Quality performance measures in upper gastrointestinal endoscopy for lesion detection: Italian AIGO-SIED-SIGE joint position statement	11
Gastrointestinal endoscopy in children and adults: How do they differ?	11
Serum bile acids in cystic fibrosis patients – glycodeoxycholic acid as a potential marker of liver disease	11
Clinical features and psychological impact of celiac disease at diagnosis	11
Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab – A prospective, multicenter cohort from Hungary	11
Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis	11
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)	11
Unexpectedly low accuracy of GPT-4 in identifying common liver diseases from CT scan images	11
Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival	11
Liver involvement in patients with erythropoietic protoporphyria	11
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer	11
Histopathology of non-IBD colitis practical recommendations from pathologists of IG-IBD Group	11
A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation	11
Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses	11
Medical therapy versus surgery in moderate-to-severe ulcerative colitis	11
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis	11
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials	11
Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency	10
Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know	10
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial	10
Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters	10
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors	10
Sexual dysfunction in gastroenterological patients: Do gastroenterologists care enough? A nationwide survey from the Italian Society of Gastroenterology (SIGE)	10
Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk	10
Antitissue transglutaminase antibodies’ normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience	10
Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769–5p	10
The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions	10
Ileoanal pouch-related fistulae: A systematic review with meta-analysis on incidence, treatment options and outcomes	10
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin	10
E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription	10
Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis	10
LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628–5p/MEIS2 axis to activate the Notch pathway	10
The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis	10
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma	10
Effectiveness of double-balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography (DBE-ERCP): A multicenter real-world study	10
Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis	10
Balloon-assisted enteroscopy-based endoscopic stricturotomy for deep small bowel strictures from Crohn's disease: First cohort study of a novel approach	9
IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota	9
WHOLE-meal ancient wheat-based diet: Effect on metabolic parameters and microbiota	9
Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study	9
Risk factors for recurrent primary biliary cirrhosis after liver transplantation: A systematic review and meta-analysis	9
Efficacy and safety of cold snare polypectomy for sessile serrated polyps ≥ 10 mm: A systematic review and meta-analysis	9
Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis	9
Double-headed small-bowel capsule endoscopy: Real-world experience from a multi-centre British study	9
Older patients with eosinophilic esophagitis have high treatment response to topical steroids	9
E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis	9
Pre-procedural use of thrombopoietin-receptor agonists in cirrhosis and severe thrombocytopenia: A systematic review and meta-analysis	9
Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factors	9
Sex disparity and drug-induced liver injury	9
Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?	9
ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis	9
HOTAIR modulates hepatocellular carcinoma progression by activating FUT8/core-fucosylated Hsp90/MUC1/STAT3 feedback loop via JAK1/STAT3 cascade	9
c-Myc affects hedgehog pathway via KCNQ1OT1/RAC1: A new mechanism for regulating HSC proliferation and epithelial-mesenchymal transition	9
Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324–3p/GLYATL1 axis	9
Strictureplasties performed by laparoscopic approach for complicated Crohn's disease. A prospective, observational, cohort study	9
LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry	9
Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression	9
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab	9
Optimizing the searching for H. pylori in clinical practice with EndoFasterⓇ	9
Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease	9
Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement	9
Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII – an update	9
Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia	9
A reasoned approach to the treatment of autoimmune hepatitis	9
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease	9
Liver histology in children with glycogen storage disorders type VI and IX	9
Systematic review with meta-analysis: The prevalence, risk factors and outcomes of upper gastrointestinal tract Crohn's disease	9
Gorilla in the room: Even experts can miss polyps at colonoscopy and how AI helps complex visual perception tasks	9
BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression	9
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study	8
Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice	8
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature review	8
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy	8
Impact of colorectal cancer screening on incidence, mortality and surgery rates: Evidences from programs based on the fecal immunochemical test in Italy	8
Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study	8
Disease course and treatment outcomes of Crohn's disease patients with early or late surgery – A Danish nationwide cohort study from 1997 to 2015	8
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.	8
Small bowel cleansing for capsule endoscopy, systematic review and meta- analysis: Timing is the real issue	8
Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN)	8
Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area	8
A multisystem-compatible deep learning-based algorithm for detection and characterization of angiectasias in small-bowel capsule endoscopy. A proof-of-concept study.	8
Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?	8
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort	8
Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endo	8
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology	8
Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients	8
Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine	8
Digital single-operator cholangioscopy in diagnostic and therapeutic bilio-pancreatic diseases: A prospective, multicenter study	8
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial	8
Management of acute cholecystitis in elderly patients: A propensity score-matched analysis of surgical vs. medical treatment	8